DrugPatentWatch Database Preview
Rotigotine - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic sources for rotigotine and what is the scope of rotigotine patent protection?
Rotigotine has one hundred and twenty-seven patent family members in thirty-two countries.
There are seven drug master file entries for rotigotine. One supplier is listed for this compound.
Summary for rotigotine
| International Patents: | 127 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 58 |
| Clinical Trials: | 71 |
| Patent Applications: | 160 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for rotigotine |
| DailyMed Link: | rotigotine at DailyMed |
Synonyms for rotigotine
| (-)-(S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol |
| (-)-N-0437 |
| (2S)-2-[propyl-[2-(2-thienyl)ethyl]amino]tetralin-5-ol |
| (6S)-6-(propyl-(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol |
| (6S)-6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol |
| (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol |
| (S)-(-)-Rotigotine |
| (S)-5,6,7,8-Tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol |
| (S)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol |
| (S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol |
| (S)-6-[Propyl-(2-thiophen-2-yl-ethyl)-amino]-5,6,7,8-tetrahydro-naphthalen-1-ol |
| 1-naphthalenol, 5,6,7,8-tetrahydro-6-(propyl (2-(2-thienyl)ethyl)amino-(6S)- |
| 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, (6S)- |
| 2-(N-n-Propyl-N-2-thienylethylamino)-5-hydroxytetralin |
| 2696AH |
| 572R932 |
| 87T4T8BO2E |
| 99755-59-6 |
| A846076 |
| AB0088886 |
| AC-3547 |
| AC1L1QQG |
| AJ-08188 |
| AKOS016340728 |
| AN-12885 |
| API0026245 |
| BC677693 |
| BDBM50123626 |
| C19H25NOS |
| CAS-99755-59-6 |
| CHEBI:135351 |
| CHEMBL1303 |
| CS-0376 |
| CTK8E7903 |
| Cyclopentylcytosine |
| D05768 |
| D08XAW |
| D09OQV |
| DB05271 |
| DSSTox_CID_26772 |
| DSSTox_GSID_46772 |
| DSSTox_RID_81893 |
| DTXSID5046772 |
| EX-A1164 |
| FT-0771906 |
| GTPL941 |
| HSDB 8254 |
| HY-75502 |
| J-502471 |
| KFQYTPMOWPVWEJ-INIZCTEOSA-N |
| KS-00002WXX |
| Leganto |
| LS-178435 |
| MFCD00870193 |
| MolPort-005-941-578 |
| N 0437 |
| N 0437, (-)-isomer |
| N 0923 |
| N-0437 |
| N-0923 |
| NCGC00168748-01 |
| NCGC00168748-02 |
| Neupro |
| Neupro (TN) |
| PubChem16423 |
| RL06136 |
| Rotigotine (JAN/USAN/INN) |
| Rotigotine (USAN/INN) |
| Rotigotine [USAN:INN:BAN] |
| Rotigotine [USAN:INN] |
| Rotigotine CDS |
| Rotigotine CDS Patch |
| RT-015446 |
| s4274 |
| SC-22242 |
| SCHEMBL1088585 |
| SPM 962 |
| SPM-936 |
| SPM-937 |
| SPM-962 |
| SS-4572 |
| Tox21_112627 |
| Tox21_112627_1 |
| UNII-5QTR54Z0E1 component KFQYTPMOWPVWEJ-INIZCTEOSA-N |
| UNII-87T4T8BO2E |
| W-5179 |
| ZINC4028 |
US Patents and Regulatory Information for rotigotine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-003 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-001 | May 9, 2007 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-002 | May 9, 2007 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ucb Inc | NEUPRO | rotigotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 021829-004 | Apr 2, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for rotigotine
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2002118325 | ➤ Sign Up |
| Australia | 2003258539 | ➤ Sign Up |
| European Patent Office | 1386605 | ➤ Sign Up |
| China | 100558350 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for rotigotine
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 269 | Luxembourg | ➤ Sign Up | 91269, EXPIRES: 20210215 |
| /2006 | Austria | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE; REGISTRATION NO/DATE: EU/1/05/331/001 - EU/1/05/331/013 20060215 |
| 1033978/01 | Switzerland | ➤ Sign Up | TEILUEBERTRAGUNG |
| 2006 00020 | Denmark | ➤ Sign Up | PRODUCT NAME: ROTIGOTINE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
